India’s Central Drugs Standard Control Organisation (CDSCO) has released new guidelines that allow the compounding of minor drug-related violations, marking a significant step toward faster enforcement, improved compliance, and reduced litigation within the pharmaceutical ecosystem.The guidelines outline specific categories of procedural and technical lapses that
India is rapidly cementing its position as a global powerhouse in the medical devices industry, driven by robust policy support, rising manufacturing capabilities, and increasing global demand for high quality, affordable medtech solutions. With a combination of strong domestic reforms and strategic international partnerships, the
In a move aimed at supporting India’s fast-growing medical device industry, the Government of India has announced the alignment of packaging and labeling rules for medical devices, easing compliance requirements and promoting regulatory clarity for manufacturers.The Department of Consumer Affairs, in coordination with the Central
In a move to strengthen drug regulation and ensure the availability of safe, high-quality medicines, Uttar Pradesh Chief Minister Yogi Adityanath announced that the state government will double the number of drug inspectors across the state. The decision is aimed at improving the monitoring of
In a significant step toward advancing medical research and innovation, the All India Institute of Medical Sciences (AIIMS), Guwahati, has inaugurated a dedicated Clinical Trial Unit (CTU) to facilitate high-quality clinical research, drug development, and evidence-based healthcare in the North-Eastern region of India.The newly inaugurated
The Pocket-Sized System Detects 35 Cardiac Determinations, Including Heart Attacks, Using a Reduced Leadset for Timely, Accurate Diagnosis of Heart Diseases.AliveCor, the global leader in AI-powered cardiology, announced the launch of its groundbreaking Kardia 12L electrocardiogram (ECG) system in India. Exclusively designed for use by
In a landmark move to safeguard the quality and reliability of diagnostic tools in Indian healthcare, the Central Drugs Standard Control Organisation (CDSCO), in partnership with the Indian Council of Medical Research (ICMR), has released comprehensive draft standard evaluation protocols for issuing licenses to In-Vitro
Indian manufacturers urge for stricter scrutiny, citing data privacy, quality, and national security concernsIndia’s domestic medical technology (MedTech) manufacturers have raised serious alarms regarding the increasing penetration of Chinese medical devices in the Indian healthcare ecosystem, flagging major concerns about national security, data privacy, and
Rising Alarms Over Substandard Drugs NITI Aayog has initiated a review following alarming data from the Central Drugs Standard Control Organisation (CDSCO), which revealed that multiple micro, small, and medium enterprise (MSME) pharmaceutical firms in India are producing substandard medications, prompting calls for strengthened oversight and
Eyestem Research Pvt Ltd announced the completion of its phase one study for its investigational retinal pigment epithelium (RPE) cell therapy, Eyecyte-RPE. The clinical study report of the study has been submitted to the Central Drugs Standard Control Organisation (CDSCO) for permission to start the phase 2 study.The
